Khaled Abousaleh
-
07. 04. 26

Zynnon sponsor at ESCMID – European Society of Clinical Microbiology and Infectious Diseases 2026

Schindellegi, Switzerland, April 07th, 2026

๐ŸŒŸ ๐ƒ๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐๐ฅ๐จ๐จ๐๐ฌ๐ญ๐ซ๐ž๐š๐ฆ ๐ˆ๐ง๐Ÿ๐ž๐œ๐ญ๐ข๐จ๐ง ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ !

We are pleased to announce that Zynnon will be participating in ESCMID – European Society of Clinical Microbiology and Infectious Diseases 2026, taking place in Munich, Germany from 17-21 April, as a sponsor and exhibitor (Booth H02 / Hall B2).

During the congress, we will be showcasing our innovation solution ๐๐š๐œ๐ญ๐ข๐Ÿ๐ฒแต€แดน, at our booth and look forward to presenting its potential to the infectious diseases community.

We are also excited to share that our abstract has been accepted for presentation (details below).

In addition, a dedicated session highlighting our innovation will take place at the Innovation & Pipeline Theater, presented by Dr. Mark Miller (details below).

๐ŸŒŸ ๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐๐จ๐ฌ๐ญ๐ž๐ซ | ๐‡๐š๐ฅ๐ฅ ๐๐Ÿ‘

๐Ÿ“… ๐ƒ๐š๐ญ๐ž: 18 April 2026
โฐ ๐“๐ข๐ฆ๐ž: 12:00 โ€“ 13:30
๐Ÿ“Œ ๐‹๐จ๐œ๐š๐ญ๐ข๐จ๐ง: Poster Hall B3
๐Ÿ†” ๐๐จ๐ฌ๐ญ๐ž๐ซ ๐๐ฎ๐ฆ๐›๐ž๐ซ: P2075
๐Ÿ“ ๐๐จ๐ฌ๐ญ๐ž๐ซ ๐“๐ข๐ญ๐ฅ๐ž: A rapid inexpensive innovative semi-automated technology to detect positive blood culture bottle growth by headspace volatile organic compounds (VOC) analysis
๐Ÿ—ฃ ๐๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐ž๐ซ: Dr. Mark Miller

๐ŸŒŸ ๐‰๐จ๐ข๐ง ๐จ๐ฎ๐ซ ๐๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง | ๐‡๐š๐ฅ๐ฅ ๐๐Ÿ | ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง & ๐๐ข๐ฉ๐ž๐ฅ๐ข๐ง๐ž ๐“๐ก๐ž๐š๐ญ๐ž๐ซ

๐Ÿ“… ๐ƒ๐š๐ญ๐ž: 20 April 2026
โฐ ๐“๐ข๐ฆ๐ž: 12:30 โ€“ 12:50
๐Ÿ“Œ ๐‹๐จ๐œ๐š๐ญ๐ข๐จ๐ง: Hall B2
๐Ÿ“ ๐๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐ญ๐ข๐ญ๐ฅ๐ž: ๐๐š๐œ๐ญ๐ข๐Ÿ๐ฒแต€แดน: rapid inexpensive semi-automated detection of positive blood cultures by VOC identification
๐Ÿ—ฃ ๐’๐ฉ๐ž๐š๐ค๐ž๐ซ: Dr. Mark Miller

Looking forward to engaging discussions, exchanging insights, and connecting with partners in infectious diseases and microbiology.

If youโ€™re attending ESCMID, we would be delighted to meet โ€” feel free to reach out or join one of the sessions!

About Zynnon

Zynnon (www.zynnon.com) is a startup transforming infectious pathogen diagnostics, minimizing operations within the laboratory and speeding up the transmission of vital pathogen information to the treating physician in order to optimize treatments and improve patient outcomes. This gaseous biomarker-based solution for the detection of Volatile Organic Compounds (โ€œVOCsโ€) is used to rapidly and precisely identify bacterial and fungal pathogens to the genus and species level. The VOC-detection and differentiation technology serves as a rapid and efficient alternative or add-on to traditional pathogen identification laboratory methods, substantially shortening the timeline from sample collection to actionable lab results. By streamlining complex procedures into a simple, small, compact, and easy-to-operate sensor-based VOC detector, along with a validated VOC database, the need for specialized laboratory skills for pathogen detection and classification (such as PCR  and/or immunoassay-based techniques) is eliminated.

Regulatory Status: CE mark and FDA in progress.

Disclaimer: Product not yet available on the market, not for sale.

For media inquiries and additional information, please contact:

Khaled Abousaleh / Zynnon AG

Email: khaled.abousaleh@zynnon.com